Programmed cell death protein (PD-1) and programmed death-ligand (PD-L1) inhibitors are most established and have been approved for the therapy of advanced melanoma, metastatic non-small cell lung cancer and multiple other types of cancer [3]. Here, CD274 is linked to cancer.